Chief Executive Officer
Jivana Biotechnology, Inc.

Sidney Hopps has over 18 years experience in international financial markets in equity and equity derivatives securitization and sales in New York, Chicago, London, and Paris.

Prior to joining Jivana Biotechnology, Mr. Hopps spent years working with biotechnology companies in the public markets while at UBS and First Albany Corp.   Mr. Hopps is responsible for developing the firm’s legal and regulatory pathways, capital raising, drug delivery technology alliances, and managing pre clinical trials. Mr. Hopps is a member of 700 for Science, a collaborative community dedicated to bringing early stage biotechnologies to life.